Abstract
To assess the 1) Acceptability and feasibility of online and paper versions of the MEPA III screener in patients with Parkinson's disease (PD), and 2) Test retest reliability of the screener. For the first objective, participants with PD completed the online and paper screeners five to seven days apart followed by an exit questionnaire. The latter included a 65-point system usability scoring (SUS) method.
Highlights
The slow loss of dopaminergic neurons in Parkinson’s disease (PD) impacts motor and non-motor functions, resulting in symptoms such as cognitive decline, decreased range of mobility, and dyskinesia
Based on preliminary testing, the Mediterranean Eating Patterns of Americans (MEPA) III scores were similar as was rating of the acceptability of the paper and online screeners by patients with PD
These symptoms can lead to impaired independence and eating behaviors, affecting nutrition status [3]
Summary
The slow loss of dopaminergic neurons in Parkinson’s disease (PD) impacts motor and non-motor functions, resulting in symptoms such as cognitive decline, decreased range of mobility, and dyskinesia. These symptoms can lead to impaired independence and eating behaviors, affecting nutrition status [3]. There is limited research assessing nutrition status in patients with PD, though there are a few reports on accordance to the Mediterranean diet (MedDiet) and risk of PD diagnosis [4,5,6]. The relative validity of a brief online dietary tool to assess accordance to a Mediterranean diet pattern, the Mediterranean Eating Patterns of Americans (MEPA) III screener has been demonstrated [1]. Further research was necessary to assess usability and the reliability (stability) of this 21-item screener
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
